news aktuell GmbH

The Second Annual Award Ceremony for International Video Contest of My China Story held in Yantai

Del

Beijing: Nearing the end of 2020, an eventful year for most, China International Publishing Group (CIPG) hosts the My China Story award ceremony for excellent films created by foreigners both abroad and living in China. Content creators from around the world document their lives and experiences in China through filming short videos.

The event begins with the screening event where guests gather to view 33 award-winning short films, getting the opportunity to view the “China Stories” experienced by other foreigners just like themselves.

After the screening, everyone headed upstairs to participate in the seminar, where several guests took the stage and shared ideas for improving how we document our experiences in or with China and how we go about sharing our stories with the world. At the seminar, video creator, Leo, from Germany, shares with us his first time in China nearly 40 years ago in 1984 and his reflections about life in China at that time. Father-son YouTube duo from the UK, Lee and Oli Barrett, also relate their experience filming and visiting the “enormous” Three Gorges Dam for the first time.

Downstairs, Liu Bianjing, a university student in China from Cameroon Africa, prepares to take the stage. He claims to be one of the best, if not the best, foreign singers of traditional Chinese Henan Opera; previously having won second prize on television competing against Chinese singers.

The grand prize is revealed by the host, awarding RMB30,000 to the first prize winner for their film about the magnificent annual gala performance and the tight-knit community of workers in a Chinese factory.

The video follows American host, Jack, who takes us through the ceremony showing us the most interesting, note-worthy highlights. We get a chance to talk to content creators and briefly hear exactly what it is they do in China that makes their own experience so unique.

For å se denne videoen, må du gi ditt samtykke øverst på denne siden.

Kontakter

Jack Klumpp
Tel: 008610-26538513
Email: jack_klumpp@yahoo.com

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release

youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye